IRIS Biomedical's parent company (Ripple) supports Synchron's successful ongoing U.S. BCI study (SWITCH)

Ripple congratulates Synchron on its groundbreaking BCI work and recent publication in JAMA Neurology!

We are excited to be a key technology partner for Synchron and support their SWITCH trial with our industry-leading implantable neural sensing platform.

Read the full article here!